Venture Round - Medherant

Venture Round - Medherant

Investment Firm

Overview

Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.

Announced Date

Apr 03, 2023

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Mercia Asset Management

Mercia Asset Management

Mercia Asset Management is a debt and early_stage_venture and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorMercia Asset Management

Round Details and Background

Medherant raised $3602095 on 2023-04-03 in Venture Round

Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 03, 2018
Grant - Medherant
1-67.3K
May 21, 2019
Series A - Medherant
1-2.2M
Apr 03, 2023
Venture Round - Medherant
1-3.6M
Sep 26, 2016
Seed Round - Medherant
1-1.9M

Recent Activity

There is no recent news or activity for this profile.